marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy..
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".
upgrade to premium